Yuanke Li

Key Laboratory Of Bioactive Materials For The Ministry Of Education, State Key Laboratory Of Medicinal Chemical Biology
Changhongjie, 300071, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Redefining Tumor Vascular Permeability through Deep Learning-Guided Microneedle Delivery.

Redefining Tumor Vascular Permeability through Deep Learning-Guided Microneedle Delivery.

Journal: ACS nano

Published: February 09, 2026

Oncolytic virus-induced IL-1β+ monocyte-IL-6+ CAF axis suppresses dendritic cell-mediated antitumor immunity in pancreatic cancer.

Oncolytic virus-induced IL-1β+ monocyte-IL-6+ CAF axis suppresses dendritic cell-mediated antitumor immunity in pancreatic cancer.

Journal: Journal for immunotherapy of cancer

Published: October 29, 2025

Granzyme B-mimetic nanozyme for nanovesicle targeted anticancer applications.

Granzyme B-mimetic nanozyme for nanovesicle targeted anticancer applications.

Journal: Nature communications

Published: October 24, 2025

Modular Design of T Cell Nanoengagers for Tumor Immunotherapy via Genetically Engineered Lipid-Tagged Antibody Fragments.

Modular Design of T Cell Nanoengagers for Tumor Immunotherapy via Genetically Engineered Lipid-Tagged Antibody Fragments.

Journal: Advanced materials (Deerfield Beach, Fla.)

Published: February 14, 2025

Targeting Brain Drug Delivery with Macromolecules Through Receptor-Mediated Transcytosis.

Targeting Brain Drug Delivery with Macromolecules Through Receptor-Mediated Transcytosis.

Journal: Pharmaceutics

Published: December 13, 2024

Single-cell data-driven design of armed oncolytic virus to boost cooperative innate-adaptive immunity against cancer.

Single-cell data-driven design of armed oncolytic virus to boost cooperative innate-adaptive immunity against cancer.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: June 13, 2024

Reprogramming macrophage by targeting VEGF and CD40 potentiates OX40 immunotherapy.

Reprogramming macrophage by targeting VEGF and CD40 potentiates OX40 immunotherapy.

Journal: Biochemical and biophysical research communications

Published: January 15, 2024

Z3495, a LysR-Type Transcriptional Regulator Encoded in O Island 97, Regulates Virulence Gene Expression in Enterohemorrhagic Escherichia coli O157:H7.

Z3495, a LysR-Type Transcriptional Regulator Encoded in O Island 97, Regulates Virulence Gene Expression in Enterohemorrhagic Escherichia coli O157:H7.

Journal: Microorganisms

Published: December 13, 2023

Genetically engineered membrane-based nanoengagers for immunotherapy of pancreatic cancer.

Genetically engineered membrane-based nanoengagers for immunotherapy of pancreatic cancer.

Journal: Journal of nanobiotechnology

Published: November 24, 2023

Tumor Cell Nanovaccines Based on Genetically Engineered Antibody-Anchored Membrane.

Tumor Cell Nanovaccines Based on Genetically Engineered Antibody-Anchored Membrane.

Journal: Advanced materials (Deerfield Beach, Fla.)

Published: September 27, 2022

Combining Doxorubicin-Conjugated Polymeric Nanoparticles and 5-Aminolevulinic Acid for Enhancing Radiotherapy against Lung Cancer.

Combining Doxorubicin-Conjugated Polymeric Nanoparticles and 5-Aminolevulinic Acid for Enhancing Radiotherapy against Lung Cancer.

Journal: Bioconjugate chemistry

Published: April 06, 2022

CD40L-armed oncolytic herpes simplex virus suppresses pancreatic ductal adenocarcinoma by facilitating the tumor microenvironment favorable to cytotoxic T cell response in the syngeneic mouse model.

CD40L-armed oncolytic herpes simplex virus suppresses pancreatic ductal adenocarcinoma by facilitating the tumor microenvironment favorable to cytotoxic T cell response in the syngeneic mouse model.

Journal: Journal for immunotherapy of cancer

Published: December 28, 2021

Showing 1-12 of 12

Last Updated: 09/26/2026